| Best &Taylor. Bases Fisiológicas de la Práctica Médica C Dvorkin Ed. Médica Panamericana, 2010 | 225 | 2010 |
| Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults D Gómez-Almaguer, MA Herrera-Rojas, JC Jaime-Pérez, ... Blood, The Journal of the American Society of Hematology 123 (25), 3906-3908, 2014 | 102 | 2014 |
| Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias D Gómez-Almaguer, M Solano-Genesta, L Tarín-Arzaga, ... Blood, The Journal of the American Society of Hematology 116 (23), 4783-4785, 2010 | 95 | 2010 |
| Danazol as first-line therapy for aplastic anemia JC Jaime-Pérez, PR Colunga-Pedraza, CD Gómez-Ramírez, ... Annals of hematology 90 (5), 523-527, 2011 | 85 | 2011 |
| The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the … GJ Ruiz-Argüelles, D Gomez-Almaguer, A Morales-Toquero, ... Bone marrow transplantation 36 (12), 1043-1047, 2005 | 75* | 2005 |
| High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia D Gómez‐Almaguer, L Tarín‐Arzaga, B Moreno‐Jaime, JC Jaime‐Pérez, ... European journal of haematology 90 (6), 494-500, 2013 | 74 | 2013 |
| Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? GJ Ruiz-Argüelles, LC Tarin-Arzaga, ML Gonzalez-Carrillo, ... Bone marrow transplantation 42 (1), 23-28, 2008 | 66 | 2008 |
| Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: the Mexican experience D Gómez‐Almaguer, J Vela‐Ojeda, JC Jaime‐Pérez, ... American journal of hematology 81 (3), 157-161, 2006 | 65 | 2006 |
| Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial C Mancías-Guerra, AR Marroquín-Escamilla, O González-Llano, ... Cytotherapy 16 (6), 810-820, 2014 | 63 | 2014 |
| Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico JC Jaime-Pérez, AC Heredia-Salazar, OG Cantú-Rodríguez, ... The Oncologist 20 (4), 386-392, 2015 | 59 | 2015 |
| Síndrome de Hellp, diagnóstico y tratamiento CH Gutiérrez-Aguirre, J Alatorre-Ricardo, O Cantú-Rodríguez, ... Revista de Hematología 13 (4), 195-200, 2012 | 59 | 2012 |
| Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia CM Luna-Aguirre, M de la Luz Martinez-Fierro, F Mar-Aguilar, ... Cancer Biomarkers 15 (3), 299-310, 2015 | 50 | 2015 |
| Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study CH Gutierrez-Aguirre, D Gomez-Almaguer, OG Cantu-Rodriguez, ... Bone marrow transplantation 40 (6), 535-539, 2007 | 45 | 2007 |
| Outpatient allografting using non-myeloablative conditioning: the Mexican experience OG Cantú-Rodríguez, JC Jaime-Pérez, CH Gutiérrez-Aguirre, ... Bone marrow transplantation 40 (2), 119-123, 2007 | 45 | 2007 |
| Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant JC Jaime-Pérez, PR Colunga-Pedraza, B Gutiérrez-Gurrola, ... Blood Cells, Molecules, and Diseases 51 (1), 61-65, 2013 | 38 | 2013 |
| Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus IV melphalan J Vela-Ojeda, MA Garcia-Ruiz-Esparza, Y Padilla-Gonzalez, ... Annals of Hematology 86, 277-282, 2007 | 37 | 2007 |
| Long-term insulin independence in type 1 diabetes mellitus using a simplified autologous stem cell transplant OG Cantú-Rodríguez, F Lavalle-González, MÁ Herrera-Rojas, ... The Journal of Clinical Endocrinology & Metabolism 101 (5), 2141-2148, 2016 | 36 | 2016 |
| All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA … MA Sanz, P Montesinos, HT Kim, GJ Ruiz-Argueelles, MS Undurraga, ... Annals of hematology 94, 1347-1356, 2015 | 36 | 2015 |
| Comparative analysis of iron status and other hematological parameters in preeclampsia CH Gutierrez-Aguirre, JA García-Lozano, OR Treviño-Montemayor, ... Hematology 22 (1), 36-40, 2017 | 34 | 2017 |
| Allogeneic peripheral blood stem cell transplantation using reduced‐intensity conditioning in an outpatient setting in ABO‐incompatible patients: are survival and graft‐versus … CH Gutiérrez‐Aguirre, A Gómez‐De‐León, J Alatorre‐Ricardo, ... Transfusion 54 (5), 1269-1277, 2014 | 32 | 2014 |
